The cancer patient and quality of life.

  title={The cancer patient and quality of life.},
  author={Andrew Bottomley},
  journal={The oncologist},
  volume={7 2},
Over the last decade, clinicians have accepted that while survival and disease-free survival are critical factors for cancer patients, overall quality-of-life is fundamental. This review considers recent developments in the field of quality of life, oncological challenges and future directions. 

Tables from this paper

Quality of life after hepatic resection

Long‐term quality of life (QoL) after liver resection is becoming increasingly important, as improvements in operative methods and perioperative care have decreased morbidity and mortality rates. In

An international phase 3 trial in head and neck cancer: Quality of life and symptom results

Detailed effects of both treatment arms on health‐related quality of life (HRQOL) and symptoms are reported.

Quality of Life Considerations in Gynecologic Cancer

  • R. PensonL. WenzelI. VergoteD. Cella
  • Medicine, Psychology
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2006

Quality of Life in Ovarian Cancer Treatment and Survivorship

The past two decades have witnessed an unprecedented level of attention devoted to the assessment of Quality of Life (QOL) in cancer patients, and QOL issues and its measure‐ ment became particularly important in oncology throughout the different phases of the cancer trajectory.

Importance of quality of life in patients with non-small-cell lung cancer.

The concept of the quality of life in patients with NSCLC is examined, as well as giving an evaluation and interpretation of the results of various clinical trials, and the new technological methods used in daily clinical practice to measure thequality of life are described.

Effect of patient and patient–oncologist relationship characteristics on communication about health‐related quality of life

Objective: To test the effects of patient and patient–oncologist relationship factors on the time spent communicating about health‐related quality of life (HRQOL) during outpatient clinic encounters

Contemporary quality of life issues affecting gynecologic cancer survivors.

Assessing health-related quality of life in cancer trials

The rationale for measuring health-related quality of life outcomes in cancer trials, and key design and methodological considerations in clinical trial settings are described.

Does the assessment of the quality of life in metastatic colon cancer in clinical practice make sense? Voice for discussion

Previous QOL questionnaires may be insufficient, especially for the population treated in daily clinical practice, and factors independent of the therapy, such as: other concomitant diseases, non-oncology treatment, oncological knowledge and the resulting health-enhancing lifestyle and other effects on QOL.

Health‐related quality of life, psychosocial functioning, and unmet health needs in patients with sarcoma: A systematic review

Health‐related quality of life (HRQoL), psychosocial distress, and unmet health needs are important patient‐reported outcomes (PROs) for patients with sarcoma treated with curative intent. Syntheses




Endpoints in cancer clinical trials: is there a need for measuring quality of life?

  • R. Feld
  • Medicine
    Supportive Care in Cancer
  • 2004
Quality-of-life assessments might best be utilized in trials in which survival differences between treatments are expected to be small, which is frequently the case.

Quality of life in cancer patients--an hypothesis.

  • K. Calman
  • Psychology
    Journal of medical ethics
  • 1984
An hypothesis is proposed which suggests that the quality of life measures the difference, or the gap, at a particular period of time between the hopes and expectations of the individual and that individual's present experiences.

Interpretation of quality of life changes

Possible ways of evaluating quality of life measures in terms of patient-clinician interactions and how the clinician can assess the importance of these changes of QOL in Terms of treatment and management of disease are discussed.

Quality of life instruments in oncology.

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

Continuous chemotherapy is better than intermittent chemotherapy for advanced breast cancer, as tested, and changes in the quality of life were independent prognostic factors in proportional-hazards models of subsequent survival.

Quality of life assessment. An independent prognostic variable for survival in lung cancer

It is suggested that nonmedical factors, such as quality of life assessment and marital status, play a role in survival and that they should be evaluated and described as potential predictors of survival in cancer patients in clinical trials.

Quality-of-life assessment in cancer treatment protocols: research issues in protocol development.

Many of the problems that quality-of-life studies have encountered could be addressed and alleviated during protocol development, and this discussion is intended to assist and stimulate investigators conducting research in this area.

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life.

Symptom reporting in cancer patients II

The authors have investigated whether social desirability is associated with patients' symptom and health behavior reporting and found that patients' appraisal of somatic symptoms is correlated with their negative affect.